A nomenclature system for labeling cyclic peptide fragments  by Ngoka, Lambert C.M & Gross, Michael L
APPLICATION NOTE
A Nomenclature System for Labeling Cyclic
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A nomenclature system for labeling fragment ions of cyclic peptides is proposed. A fragment
ion is labeled with a four-part descriptor of the general formula xnJZ, where x is the designation
for the ion (e.g., lower case a or b, as are used for peptide fragments) and n is the number of
amino acid residues in the ion. A b ion is the usual acylium ion or isomeric equivalent
consisting of n amino-acid residues, and this ion may lose carbon monoxide to form an a ion.
The subscripts J and Z are the one-letter (upper-case) codes for the two amino-acid residues
connecting the backbone amide or ester bond, J–Z, that can be viewed as broken to form the
decomposing linear ion. The symbol J is for the N-terminal amino-acid residue, and Z is that
for the C-terminal amino-acid residue that result from the bond cleavage. The nomenclature
system is applicable to a wide range of cyclic peptides, including depsipeptides, cyclic
peptides containing modified or unusual amino acids, cyclic peptides bearing a linear peptide
moiety, and cyclic peptides that are introduced into the gas phase as metal–ion cationized
species. (J Am Soc Mass Spectrom 1999, 10, 360–363) © 1999 American Society for Mass
Spectrometry
Although cyclic peptides are encountered in massspectrometry less often than linear peptides,they are a large and diverse class of natural
products and synthetic compounds whose structures
often need to be determined or verified. Mass spectrom-
etry is an important tool for sequencing cyclic peptides
[1]. Despite its potential and its successes in natural-
product chemistry, no systematic nomenclature system
for designating product ions has found wide accep-
tance. This, of course, is not the case for linear peptides,
where the nomenclature system of Roepstorff and Fohl-
man [2] as later modified by Biemann [3] has been
universally adopted. The nomenclature system for lin-
ear peptides is not directly applicable to cyclic peptides,
however, because cyclic peptides do not have N- or
C-terminal ends.
Tuinman and Pettit [4] suggested a system for label-
ing the product-ion spectra of cyclic peptides, but the
system has some drawbacks. First, the system uses
descriptors that are inconsistent with those of the
Roepstorff system. This is a source of confusion
whereby a particular label would indicate two different
fragment ions depending on whether the Roepstorff
and Fohlman or Tuinman and Pettit system were used.
Second, the Roepstorff and Fohlman symbols (a1, b1, c1,
x1, y1, z1, etc.) are used without giving an indication as
to the amino-acid residue at which the numbering
should begin. This creates confusion because there
would be n2 (where n is the number of amino acid
residues in the cyclic peptide) sets of descriptors needed
to label all the fragment ions of a given cyclic peptide.
Third, the system employs a large number of characters
compared to the relatively simple system used for linear
peptides. Fourth, fragment ions of a cyclic peptide are
not equivalent to internal fragment ions of a linear
peptide because latter fragments do not contain the
original N- or C-terminal amino acid residues; fragment
ions of cyclic peptides often contain the N-terminus of
the ring-opened form of the cyclic peptide.
For most cyclic peptides, fragmentation follows pro-
tonation of the peptide bond to open the ring and give
an open-chain acylium ion or isomeric equivalent. The
cleaved amide nitrogen becomes the N terminus, and
the acylium-ion site can be viewed as the C terminus.
Product ions are formed mainly by charge-driven scis-
sion of amide linkages resulting in loss of one or more
amino-acid residues from the C-terminus. The result is
a series of product ions containing the N terminus of the
newly formed linear peptide residue. For cyclic dep-
sipeptides (i.e., those containing an ester linkage instead
of an amide linkage as part of the backbone), cleavage at
the ester bond can be viewed to give an “N terminus”
consisting of an alcohol functional group and a C
terminus as determined by the acylium ion.
We propose here a nomenclature system for desig-
nating the product ions formed from typical cyclic
peptides (i.e., those composed of the 22 common amino
acids), from cyclic peptides with modified or unusual
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amino acids, from cyclic depsipeptides, and from cyclic
peptides that are desorbed as metal-cationized species.
Experimental
The cyclic peptides were purchased from Sigma Chem-
ical (St. Louis, Mo) and were used without further
purification.
High-energy collisionally activated decomposition
(CAD) spectra were obtained on a ZAB T four-sector
tandem mass spectrometer (Micromass, Manchester,
UK) that was described previously [5]. Precursor ions
were produced by FAB using 3-nitrobenzyl alcohol as
the matrix and a 25-keV cesium-ion beam. The precur-
sor ions were selected by the first-stage mass spectrom-
eter at a resolving power of 1500 after acceleration
through 8 kV. The collision cell was floated at 4 kV, and
sufficient helium gas was introduced to the cell to
attenuate the precursor ion beam by 50%. The product-
ion mass spectrum was recorded by scanning the sec-
ond-stage mass spectrometer, using the point detector,
and processing the data with a DEC Alpha 3000 work-
station that was provided by the manufacturer.
Low-energy CAD spectra were recorded with a
Finnigan (San Jose, CA) LCQ ion-trap mass spectrom-
eter. Precursor ions were produced by electrospray
ionization (ESI) in which a 250 fmol/mL solution of the
cyclic peptide, dissolved in 20/80/1 methanol/water/
formic acid solution, was introduced to the sprayer via
a 250 mL Hamilton syringe (Hamilton, Reno, NV) at a
flow rate of 2 mL/min. The capillary temperature was
200 °C, and its voltage was 650 V.
Results and Discussion
To illustrate the nomenclature system, we begin with
the high-energy CAD spectrum (Figure 1) of the cyclic
peptide (Pro–Gly)3. If the initial fragmentation is initi-
ated at the proline amide bond to form a linear peptide
of the same mass; we designate this ion as b6GP, which
presumably fragments by loss of one or more amino-
acid residues from the C terminus to give “acylium
ions:” b5GP, b4GP, b3GP, b2GP, and after loss of CO, a2GP.
The subscripts “nGP” communicate that the fragments
are assumed to be formed upon protonation at Pro and
ring opening at the P–G amide bond, and the numerical
subscript (n) indicates the number of amino-acid resi-
dues retained in the product ion. Other mechanisms
may form the various product ions, but that is not
relevant to the nomenclature system. The designation is
unambiguous in this case. Because the molecule is
symmetrical and made of three repeating units of two
amino acids, ring opening can occur at three sites, but
the ring-opened precursor ions are identical for this
cyclic peptide.
The nomenclature for a cyclic peptide that contains
an unusual or modified amino acid or hydroxy acid, the
number of Arabic letters that can be used to designate
those constituents is limited because 22 letters are
already taken to designate the 22 usual amino acids.
Figure 1. High-energy CAD mass spectrum of FAB-produced [M 1 H]1 of cyclo(Pro–Gly)3.
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Additional characters may be generated by priming the
usual symbols (e.g., N-methylalanine can be defined as
A9) or by using special computer fonts such as “sym-
bol.” It is incumbent upon the author of an article
describing the spectra to make clear the definitions.
Another example is the low-energy CAD spectrum
of cyclo(D-Trp–Lys–Thr–Phe–Pro–Phe). Presumably,
ring opening occurs at three different sites: at Trp–Phe,
Thr–Lys, and Pro–Phe linkages. The ring-opened pre-
cursor ions can be viewed as b6WF, b6TK, and b6PF,
respectively. Each is the origin of a series of product
ions: bnWF, bnTK, and bnPF, where n 5 1–5. In fact, the
low-energy CAD spectrum (Figure 2) of the ESI-pro-
duced precursor shows that many members of the
series are formed.
It may be useful to study the CAD of a metal–ion
cationized cyclic peptide if simplified fragmentations
are desired, as we demonstrated in a recent article [6].
The nomenclature is easily modified in that case. For
example a [b6WF 2 H 1 Na]
1 may be simply desig-
nated as b6WF
* , a modification that is now commonly
used for metal–ion cationized linear peptides.
The nomenclature is readily adapted to the fragmen-
tation of more complex peptides that are composed of
both linear and cyclic moieties. An example is [Asu1,6]–
oxytocin fragment, cyclo(Tyr–Ile–Gln–Asn–Asu)–Pro–
Leu–Gly–NH2 (mol. wt. 955). The substance contains
the unusual amino acid, a-amino suberic acid (Asu),
H2NCH[(CH2)5COOH]COOH, which could be desig-
nated as U or by the Greek letter S. The low-energy
CAD spectrum (not shown) of the [M 1 H]1 is domi-
nated by a fragment of m/z 672, which is the cyclic
moiety retaining a –(CH2)5CO
1 side chain of Asu and
which is formed by loss of 284 Da. Upon collisional
activation of the m/z 672 ion, ring opening occurs at
the Asn–Gln peptide bond, presumably by proton rear-
rangement from the side chain of Asu to the amide. The
resulting series of product ions (relative abundances
between 10% and 95%) may be designated by using the
proposed nomenclature and specifying the mass of the
expelled neutral: [a5NQ 2 284], [b4NQ 2 284], [a4NQ 2
284], [b3NQ 2 284], and [a3NQ 2 284], at m/z 644, 544,
516, 431, and 403, respectively. The designations im-
mediately identify the fragments as originating from
the cyclic-peptide moiety. To designate the fragmenta-
tion of the linear-peptide portion, the cyclic peptide
should be considered as a substituted linear peptide,
and the losses of a portion or all the cyclic peptide
portion be designated as minus the appropriate mass.
Although in these examples, we presuppose that the
decomposition pathways involve charge-driven frag-
mentation at the acylium ion site, the actual fragmen-
tations may occur elsewhere (e.g., at the N terminus).
This, however, does not affect the designation or its
utility.
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Figure 2. Low-energy CAD mass spectrum of ESI-produced [M 1 H]1 of cyclo(D–Trp–Lys–Thr–
Phe–Pro–Phe).
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